North America Cardiac Arrhythmia Monitoring Devices Market Share

Statistics for the 2023 & 2024 North America Cardiac Arrhythmia Monitoring Devices market share, created by Mordor Intelligence™ Industry Reports. North America Cardiac Arrhythmia Monitoring Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of North America Cardiac Arrhythmia Monitoring Devices Industry

The North American cardiac arrhythmia monitoring devices market consists of several major players. The companies are implementing certain strategic initiatives, such as mergers and acquisitions, new product launches, and partnerships that help them in strengthening their market position. For instance, in December 2018, iRhythm Technologies Inc. developed a new device called Zio patch, which helps patients to monitor their heartbeat. Market leaders with more funds for research and better distribution system have established their position in the market

North America Cardiac Arrhythmia Monitoring Devices Market Leaders

  1. BioTelemetry Inc.

  2. Cardiac Science Corporation

  3. GE Healthcare

  4. iRhythm Technologies Inc.

  5. Abbott Laboratories

*Disclaimer: Major Players sorted in no particular order

ACS Diagnostics, Inc., BioTelemetry Inc., Cardiac Science Corporation, GE Healthcare, iRhythm Technologies Inc., Medi-Lynx Cardiac Monitoring LLC, Koninklijke Philips NV, Abbott Laboratories, Medtronic PLC,

North America Cardiac Arrhythmia Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)